Skip to content

Clinical Study to compare two Ayurvedic eye drops (Daruharidra and Shigrupatradi) for the treatment of acute infective conjunctivitis (red eye infection)

Efficacy of Daruharidra Kwatha Aschyotana (eye drop) and Shigrupatradi Aschyotana (eye drop) in the management of Amaja Abhishyanda (Acute Infective Conjunctivitis) - an open labelled randomized controlled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110715
Enrollment
60
Registered
2026-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda, Jamnagar, Gujarat - 361008
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between 18 to 50 years of age with irrespective of Gender, Occupation, Religion, Socio-Economic status. Patients presenting cardinal clinical feature Ragata (redness) of Amaja Abhishyanda with at least one of the following clinical features of Amaja Abhishyanda i.e. Netrasrava (discharge), Kandu (itching), Daha (burning sensation), and Sangharsha (foreign body sensation), suggestive of acute inflammatory involvement of the conjunctiva. Symptoms developed within less than 5 days.

Exclusion criteria

Exclusion criteria: Patients having complications of corneal involvement like Marginal Corneal Ulcer, Dacryocystitis, Trachoma, Keratocunjunctivitis Sicca, Vernal Keratocounjunctivitis, Chronic giant papillary conjunctivitis, Atopic Keratocojunctivits, Pterygium, Recurrent allergic conjuctivitis. Pregnant and lactating mother must be excluded. Uncontrolled systemic diseases i.e. Diabetes Mellitus, Hypertension.

Design outcomes

Primary

MeasureTime frame
Assessment of the pacification of sign and symptoms of Amaja Abhishyanda (Acute Infective Conjunctivitis)Timepoint: Day 7 and Day 15

Secondary

MeasureTime frame
Assessment of recurrence of signs and symptoms of Amaja Abhishyanda (Acute Infective Conjunctivitis)Timepoint: Day 23 and Day 30

Countries

India

Contacts

Public ContactChirag H Mandalia

Institute of Teaching and Research in Ayurveda, Jamnagar

dkpawar29@gmail.com7737379173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026